Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Urinary Bladder Neoplasms 3Prostatic Neoplasms 3Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Multiple Pulmonary Nodules 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Hodgkin Disease 1Hepatic Malignancies 1Head and Neck Neoplasms 1Glioblastoma 1Carcinoma, Transitional Cell 1Carcinoma, Hepatocellular 1Cancer Diagnosis 1Breast Cancer Metastases 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

zirconium-89-trastuzumab 1Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Breast Cancer Metastases × Positron Emission Tomography Computed Tomography × Clear all
NCT02286843 2021-06-18

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

Memorial Sloan Kettering Cancer Center

Phase NA Completed
49 enrolled 8 charts
Breast

Breast Cancer Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡